Biovaxys Technology Corp (TSE:BIOV) has released an update.
BioVaxys Technology Corp. has announced a delay in filing its annual and interim financial reports due to additional time needed by the auditor to complete the audit, which now includes the company’s recent acquisition of former IMV Inc.’s assets. Despite the setback, BioVaxys reaffirms its commitment to providing bi-weekly updates and states that there are no new material changes or insolvency proceedings affecting the company. The delayed filings are now expected by April 30, 2024, with interim reports to follow subsequently.
For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.
